Adorbs Inc

CIK:0001726822|SEC Filings

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue, net
Revenue, net	$ 16,260	$ 42,154	$ 76,871	$ 122,927
Cost of sales	6,015	5,333	26,255	44,471
Gross margin	10,245	36,821	50,617	78,456
Operating expenses
General and administrative expenses	(21,030)	31,970	34,738	64,122
Professional fees	16,242	94,716	66,500	263,607
Amortization of intangible assets	417,924	11,107	845,293	30,055
Impairment of goodwill and intangible			590,512
Total operating expenses	413,136	137,794	1,537,043	357,784
Loss from operations	(402,891)	(100,973)	(1,486,426)	(279,328)
Other income (expense)
Interest expense	(7,067)	(449)	(7,745)	(1,292)
Total other income (expense)	(7,067)	(449)	(7,745)	(1,292)
Loss from continuing operations before income taxes	(409,958)	(101,422)	(1,494,171)	(280,620)
Provision (benefit) for income taxes
Loss from continuing operations	(409,958)	(101,422)	(1,494,171)	(280,620)
Loss from discontinued operations	(5,177)	(5,760)	(15,609)	(21,086)
Net loss	$ (415,135)	$ (107,182)	$ (1,509,780)	$ (301,706)
Basic and diluted loss per share:
Loss from continuing operations - Basic	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Loss from continuing operations - DIluted	(0.00)	(0.00)	(0.00)	(0.00)
Loss from discontinued operations - Basic	(0.00)	(0.00)	(0.00)	(0.00)
Loss from discontinued operations - Diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average number of shares outstanding - Basic	598,545,644	75,000,000	598,545,644	67,324,064
Weighted average number of shares outstanding - Diluted	598,545,644	75,000,000	598,545,644	67,324,064
Comprehensive loss:
Net loss	$ (415,135)	$ (107,182)	$ (1,509,780)	$ (301,706)
Foreign currency translation adjustment	(41,622)	(20,430)	(48,871)	(37,101)
Comprehensive loss	$ (456,757)	$ (127,612)	$ (1,558,651)	$ (338,807)

Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows From Operating Activities
Net loss	$ (1,509,780)	$ (301,706)
Less : Loss from discontinued operation	(15,609)	(21,086)
Loss from continuing operations	(1,494,171)	(280,620)
Amortization of intangible assets	845,293	30,055
Impairment of goodwill and intangible assets	590,512
Changes in operating assets and liabilities:
Accounts receivable	(1,760)	(3,056)
Inventory	(3,261)	268
Accrued payable and accrued liabilities	(925)	6,999
Net cash used in operating activities -continuing operations	(64,312)	(246,354)
Net cash used in operating activities -discontinued operations	(15,609)	(21,086)
Net cash used in operating activities	(79,921)	(267,440)
Cash Flows from Investing Activities
Acquisition of a business net of cash acquired		19,981
Net cash provided by investing activities		19,981
Cash Flows From Financing Activities
Proceeds from the sale of common stock	26,607
Proceeds from convertible notes	27,778
Common stock payable		271,669
Proceeds from related party loans	984	12,821
Net cash provided by financing activities	55,369	284,490
Effect of exchange rates on cash and cash equivalents	(6,682)	15,343
Net (decrease) increase in cash and cash equivalents	(31,234)	52,374
Cash and cash equivalents, beginning of year	41,808	9,499
Cash and cash equivalents, end of year	10,574	61,873
Supplemental disclosure of cash flow information
Cash paid for income tax expense
Cash paid for interest expense

Condensed Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 10,574	$ 41,808
Accounts receivable	3,104	1,344
Inventory	38,542	35,281
Prepaid and other assets	1,181	1,179
Total current assets	53,400	79,612
Goodwill		512,196
Intangible assets	830,571	88,923
Total assets	883,972	680,731
Current Liabilities
Accrued payable and accrued liabilities	42,028	42,953
Common stock payable		843,878
Convertible note -related party	27,778
Due to related parties	228,688	227,704
Total current liabilities	298,494	1,114,535
Government loans	29,584	29,532
Total liabilities	328,078	1,144,067
Stockholders’ Equity (Deficit)
Common stock, Par Value $0.001, 700,000,000 shares authorized, 598,545,644 and 598,545,644 shares issued and outstanding of shares as of September 30, 2023 and December 31, 2022, respectively	598,546	75,000
Additional paid in capital	2,080,075	25,740
Accumulated deficit	(2,035,661)	(525,881)
Accumulated other comprehensive loss	(87,066)	(38,195)
Total stockholders’ equity (deficit)	555,894	(463,336)
Total liabilities and stockholders’ equity (deficit)	$ 883,972	$ 680,731